Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Express Scripts
Harvard Business School

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Pheniramine

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Pheniramine?

Pheniramine is an investigational drug.

There have been 33 clinical trials for Pheniramine. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2011.

The most common disease conditions in clinical trials are Rhinitis, Rhinitis, Allergic, and Sunburn. The leading clinical trial sponsors are Mantecorp Industria Quimica e Farmaceutica Ltd., EMS, and National Cancer Center, Korea.

There is one US patent protecting this investigational drug and eleven international patents.

Recent Clinical Trials for Pheniramine
Effect of the Antihistamine Injection to Prevent Paradoxical Reaction During Sedative EndoscopySeoul National University HospitalN/A
Anti-histamines Promote Electroacupuncture Analgesia: Basic and Clinical ResearchChina Medical University HospitalN/A
Effect of Anti-histamine in Prevention Systolic Hypotension After ProtamineMahidol UniversityPhase 4

See all Pheniramine clinical trials

Clinical Trial Summary for Pheniramine

Top disease conditions for Pheniramine
Top clinical trial sponsors for Pheniramine

See all Pheniramine clinical trials

US Patents for Pheniramine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pheniramine   Start Trial Heterocyclic compounds useful in the treatment of disease Epigen Biosciences, Inc. (San Diego, CA)   Start Trial
Pheniramine   Start Trial Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof   Start Trial
Pheniramine   Start Trial Ultra-pure agonists of guanylate cyclase C, method of making and using same SYNERGY PHARMACEUTICALS, INC. (New York, NY)   Start Trial
Pheniramine   Start Trial Compositions containing polymeric, ionic compounds comprising imidazolium groups BASF SE (Ludwigshafen, DE)   Start Trial
Pheniramine   Start Trial Drug combinations and uses in treating a coughing condition Infirst Healthcare Limited (London, GB)   Start Trial
Pheniramine   Start Trial Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases Halozyme, Inc. (San Diego, CA)   Start Trial
Pheniramine   Start Trial Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof Gel-Del Technologies, Inc. (St. Paul, MN)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Pheniramine

Drugname Country Document Number Estimated Expiration Related US Patent
Pheniramine Australia 2014232383 2033-03-15   Start Trial
Pheniramine Australia 2019202731 2033-03-15   Start Trial
Pheniramine Brazil 112015023267 2033-03-15   Start Trial
Pheniramine Canada 2906931 2033-03-15   Start Trial
Pheniramine China 105142635 2033-03-15   Start Trial
Pheniramine Eurasian Patent Organization 201591607 2033-03-15   Start Trial
Pheniramine European Patent Office 2988743 2033-03-15   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.